Chris’ Bio

Dr. Christina (Chris) Bodurow is a pharmaceutical industry business leader with over 35 years of experience in the global development and delivery of medicines. She has built global business units from scratch and taken small businesses to full-scale global success stories. She has direct experience with strategic, financial, resource, and capacity planning and management, including responsibilities for business unit Profit and Loss Statements. She is highly skilled and committed to people leadership: developing strong leaders who go on to take on positions of greater responsibility. She successfully energizes global business units to deliver on their missions.

Chris was raised in Dearborn, Michigan, and received her Bachelor’s degree from Kalamazoo College, and her Ph.D. in Organic Chemistry from Princeton University. Chris currently serves as the Deputy Director and Chief Operating Officer of the AViDD program at Stanford University School of Medicine. Prior to that, Chris completed a role serving as Vice-President, Global Regulatory Affairs, in the Data Sciences, Safety and Regulatory Division at IQVIA. Chris’ prior experience includes 33 years at Eli Lilly and Company. She held responsibilities including Senior Director of External Sourcing in the Medicines Development Unit (MDU), Chief Operating Officer (COO), Product Research & Development (CMC component of LRL), as well as global R&D Operations Leader for the Prozac and Xigris Product Teams.

Upon leaving Lilly, Chris formed PharmaDOQS, a consulting company to the Biopharmaceutical industry. Chris Bodurow has served in a number of professional and community volunteer roles, including on the Board of Directors of the American Chemical Society (2016-2021), multiple ACS Committees, the IU-Indianapolis Dean of Science Advisory Board, the Board of Directors of the Indianapolis Symphony Orchestra and the Kalamazoo College Board of Trustees.